Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...

At the same time, Keith Meister, managing partner and chief investment officer of the hedge fund Corvex Management, will take ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina, Inc. ILMN and Nashville Biosciences, LLC (NashBio) recently announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. The insights ...

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

Next-generation sequencing (NGS) technology, which has been used at Illumina since 2007, builds upon earlier genome sequencing methods to greatly reduce the time taken to sequence DNA. When the ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech ...

To help researchers work towards these goals, Illumina has devised two methods for sequencing SARS-CoV-2 from clinical samples: one workflow based on shotgun metagenomics, and one on target ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

(RTTNews) - Illumina, Inc. (ILMN) responded on Monday to the notice from the China Ministry of Commerce stating that it is not permitted to export sequencing instruments into China. Illumina said ...

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments.